# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Osmotica Pharmaceuticals plc (NASDAQ: OSMT) will change its name to RVL Pharmaceuticals plc and start trading under the new tic...
Osmotica Pharmaceuticals Says Q4 Net Sales For UNPEEQ Targeted To Range From $20M-$25M
Osmotica Pharmaceuticals plc (Nasdaq: OSMT) ("OSMT" or the "Company"), a specialty pharmaceutical company, anno...
Gainers 22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco pro...
Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) jumped 37.3% to $2.0182. Pasithea recently said it expanded its footprint...
Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) rose 26.5% to $1.86 in pre-market trading. Pasithea recently said it expa...
HC Wainwright & Co. analyst Douglas Tsao initiates coverage on Osmotica Pharmaceuticals (NASDAQ:OSMT) with a Buy rating ...
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors a...